Search Protocols under revision. Back New search Go to resultsDiseaseMain groupSupportive Therapy, ToxicityProtocol groupImmunodeficienciesDiseaseAntibody Deficiency, Secondary to Hematological Neoplasms / after Stem Cell TransplantationSubgroupICD10D80.9MeSHAcquired Immunodeficiency SyndromeIgG DeficiencySequenceRHUH(800/1600/2400)/SCIgG(10/20/30), Sec. Antibody Deficiency, hemat. Neoplasia, C1 (PID1722) -|- RHUH2400/SCIgG30, C2+ (PID1727)ChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceHuman immunoglobulin, intravenouslyHuman immunoglobulin, subcutaneousRecombinant Human HyaluronidaseSupportive substanceHuman immunoglobulin, intravenouslyHuman immunoglobulin, subcutaneousRecombinant Human HyaluronidaseSupportive substanceHuman immunoglobulin, intravenouslyHuman immunoglobulin, subcutaneousRecombinant Human HyaluronidaseSupportive substanceHuman immunoglobulin, intravenouslyHuman immunoglobulin, subcutaneousRecombinant Human HyaluronidaseNo. Substances12Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationTherapy phaseTherapy intentionsupportiveRisksAllergic ReactionHeadacheInfusion ReactionNauseaPainPyrexia only studiesPublicationAuthorAngelotti FChapel HDiseaseSekundäre Hypogammaglobulinämie bedingt durch eine lymphoproliferative ErkrankungSekundärer Immunglobulinmangel bei hämatologischen oder soliden NeoplasienOriginDepartment of Immunology, Oxford Radcliffe Hospital, The John Radcliffe CampusUniversity of Pisa and Azienda Ospedaliera Universitaria Pisana, Pisa, ItalyProtocols in Revision 3 protocols foundRecombinant Human Hyaluronidase (800/1600/2400) / Human immunoglobulin G (10/20/30), subcutaneous, secondary antibody deficiency, hematologic neoplasms, stem cell transplantation, Cycle 1 (PID1722 V1.1)Recombinant Human Hyaluronidase, 2400 / Human immunoglobulin G 30, subcutaneous, secondary antibody deficiency, hematologic neoplasms, stem cell transplantation, Cycle 2+ (PID1727 V1.1)Intravenous immunoglobulin-G 250, secondary antibody deficiency, hematologic neoplasms, stem cell transplantation (PID832 V1.0)
